The Biological Safety Testing Products and Services Market size was valued at $4.42 Bn in 2023 & will reach $10.51 Bn by 2032 & growing at a CAGR of 10.10% Over the Forecast period of 2024-2032.
The main factors driving the growth of the biological safety testing market include the increasing prevalence of target diseases and growth in the number of next-generation biologic production by different biotechnology and pharmaceutical companies. For example, in September 2022, Novartis announced an investment of USD 300 million in next-generation biotherapeutics, aimed to expand the early technical biologic’s capacity. The growing need for biologics has led to a notable rise in the number of biopharmaceutical companies.
Moreover, increased competition in producing highly effective therapies on a large scale has allowed manufacturers to concentrate on improving various facets of industrial processes and cost-effectiveness. For instance, in July 2023, Biocon Biologics, an India-based firm, launched Humira, a rheumatoid arthritis drug that is a biosimilar to AbbVie, the US-based company, at a reduced price, readily available throughout the region. As a result, many companies are implementing better manufacturing practices, where each step of the production cycle is biologically evaluated and readily available across all levels, thereby promoting the growth of the target market.
Therefore, in response to the increased prevalence of microbial contamination and bioburden during the production of pharmaceuticals and biologics, governments and private organizations are expected to improve their underlying biological safety practices. The strict safety standards imposed by regulatory bodies are expected to drive regional market growth by motivating both biopharmaceutical companies and other organizations to adopt testing tools. For example, in June 2023, the US FDA introduced a guideline called “BioRationality” that allowed biosimilar developers to adopt cost-effective evaluation methods for a more scientifically rational and efficient development and approval process.
The new guideline is estimated to reduce the cost of biosimilar development by proposing alternative evaluation methods to facilitate the development process. Biological safety test services are used to determine the absence of bacterial contaminants and ensure that vaccines and biopharmaceuticals are safe. They also include a variety of tests such as bioburden, toxicology, and analytics. Key parameters evaluated to determine the quality of companies’ offerings include accuracy, linearity, range, and specificity.
Drivers
The Biological Safety Testing Products and Services market is primarily driven by the rapid expansion of the biopharmaceutical industry. The development of new vaccines, gene & cell therapies, antibodies, and other biologics has grown exponentially in recent years. However, these products need to be thoroughly tested in terms of safety to comply with the long list of regulatory requirements. Consequently, such well-established players as Lonza Group, Charles River Laboratories, Merck KGaA, and other leaders in the biotechnology industry invested significant amounts of money to expand the testing capabilities.
For instance, in 2023 Lonza Group is planning to expand its biological safety testing facilities in the U.S. and Europe. The company is able to execute all types of assay development, validation, and lot release testing of gene and cell therapies. Similarly, Charles River Laboratories has recently acquired Cognate BioServices, a cell and gene therapy CDMO company. It is evident that the biopharmaceutical industry is committed to test its products in terms of safety and bringing more business to the Biological Safety Testing Products and Services market.
Restrain
High Costs of Testing Procedures hamper the market growth.
The high costs associated with biological safety testing procedures stem from the intricate and stringent nature of these processes. Conducting thorough safety evaluations requires advanced equipment, such as specialized analytical instruments and containment facilities, which are expensive to acquire and maintain. Additionally, the complexity of the tests demands highly skilled professionals with expertise in biotechnology, toxicology, and related fields, further driving up operational costs. This financial barrier often hampers innovation and delays product development, as these organizations may struggle to allocate sufficient resources for comprehensive safety testing, thereby impacting their competitiveness in the market.
By Product
Reagents and kits accounted for a dominant revenue share of over 40.54% in 2023. Reagents being major components in biological safety testing, are used extensively in research as well as clinical laboratories. Different reagents and kits used in the testing and are antibiotics, attachments & matrix factors, biological buffers, freezing & dissociation reagents, miscellaneous reagents, and other reagents. The rapid development and modification in the formulation of reagents and kits are anticipated to increase the consumption of reagents and kits among laboratory technicians, especially in toxicology assessment.
Moreover, an increasing number of reagents and kits are being used on high-throughput testing samples, which fuels the demand for reagents and kits. Instruments are anticipated to exhibit lucrative growth through 2030 due to an increasing number of instruments used in biological safety testing laboratories. Furthermore, the rising regulatory pressure on biopharmaceutical companies to adhere to safety guidelines is driving the demand for instruments. Instruments are vital in performing various biological assays, including toxicology and bioburden testing. Moreover, the significant rise in the demand for specialized biological safety testing such as genetic testing, cell-based assays, electrochemiluminescence immunoassays, and flow cytometry assays for performing different procedures increases the demand for specific instruments used in these procedures.
Need any customization research on Biological Safety Testing Products and Services Market - Enquiry Now
By Application
The largest revenue share was allocated to the vaccines & therapeutics segment in 2023. Its dominance is explained by clearly defined guidelines that help ensure the safety of developed vaccines with unaltered therapeutic value and reduced toxicity. One of the central factors driving the growth of vaccines & therapeutics is the collaboration Memorandum of Understanding of BioNTech SE with the UK Government. This agreement is expected to benefit the patients by accelerating clinical trials of mRNA personalized immunotherapies.
The company is likely to concentrate on cancer immunotherapies, environmental, and infectious disease, and vaccines, thereby strengthening its presence in the UK. Another significant factor affecting the growth rate is the issuance of various guidelines and recommendations by regulatory authorities, such as the U.S. FDA, concerning the characterization and qualification of materials used in vaccines for infectious disease indications production.
By Test Type
The endotoxin tests segment of the global market experienced a high revenue share in 2023, Enabling technologies, and adoption of the endotoxin tests in several applications such as the manufacturing and production of drugs used to reduce the risk of endotoxins. For instance, In August 2022, Lonza announced the launch of Redwood Genomics’ Nebula Multimode Reader, which is the first qualified multimode reader tested for use in the company’s recombinant endotoxin detection, turbidimetric, and chromogenic methods. In addition, the availability of various types such as turbidimetric methods, gel clot endotoxin testing, and USP chromogenic endotoxin testing, that are manufactured for specific end use may stimulate the segment growth in coming years. Manufacturing of the endotoxin testing plays an important role in protecting the patient from the pyrogen-contaminated product. Therefore, the manufacturers follow this endotoxin testing for safeguarding the patient flowering adopted Pyrogen-Free products which further enhances the demand in the market.
North America held the largest market share around 37.22% in 2023. The significant share of the market held by this region is accounted for by substantial investments made by the biotechnology industry, increasing adoption in the cancer research field, and the development of novel biologics, vaccines, and drugs. Besides, market growth is ensured by rising research and development investments of companies. Moreover, the market is driven by the extensive expansion efforts made by the leading market players. Expansion is also facilitated by the growing prevalence of chronic diseases in the region, which is expected to increase the adoption of advanced technologies by researchers and healthcare professionals.
In 2023, the U.S. also held the most significant share of the North American market. The country maintains its leadership as North America’s market due to the presence of a strong and highly developed biopharmaceutical industry, as well as a strong research and development focus. Additionally, the continuous presence of countless pharmaceutical and biotechnology companies as well as academic and research institutions creates a sustainable demand for rigorous testing for safety, which ensures the leadership of the country in the area.
Some of the Key Players are Lonza, BIOMÉRIEUX, Thermo Fisher Scientific Inc., SGS Société Générale de Surveillance SA, Eurofins Scientific, Sartorius AG, Samsung Biologics, Merck KGaA, BSL Bioservice, Charles River Laboratories, and Other Players.
In 2023, Charles River expanded its biological testing capabilities by acquiring Cognate BioServices, a cell and gene therapy contract development and manufacturing organization (CDMO). This acquisition enhanced the company’s biological safety testing services for advanced therapies.
In 2023, Thermo Fisher launched its new Gibco CTS TrueCut Cas9 Protein, which is designed to improve the accuracy and efficiency of gene editing. This development supports the growing demand for safety testing in gene therapy and related biologics.
| Report Attributes | Details |
| Market Size in 2023 | US$ 4.42 Billion |
| Market Size by 2032 | US$ 10.51 Billion |
| CAGR | CAGR of10.10% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Reagents & Kits, Instruments, Services) • By Test Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication & Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Other) • By Application (Vaccines & Therapeutics, Blood & Blood-based Products, Gene Therapy, Tissue & Tissue-based Products, Stem Cell) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Lonza, BIOMÉRIEUX, Thermo Fisher Scientific Inc., SGS Société Générale de Surveillance SA, Eurofins Scientific, Sartorius AG, Samsung Biologics, Merck KGaA, BSL Bioservice, Charles River Laboratories, and Other Players. |
| Key Drivers | •Growth in Biopharmaceutical Industry Drives Market Growth. |
| RESTRAINTS | •High Costs of Testing Procedures hamper the market growth. |
Ans: The Biological Safety Testing Products and Services Market was valued at USD 4.42 billion in 2023.
Ans: The expected CAGR of the global Biological Safety Testing Products and Services Market during the forecast period is 10.10%.
Ans: The vaccines & therapeutics will grow rapidly in the Biological Safety Testing Products and Services Market from 2024-2032.
Ans: Growth in Biopharmaceutical Industry Drives Market Growth.
Ans: The U.S. led the Biological Safety Testing Products and Services Market in the North America region with the highest revenue share in 2023.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Vaccines & Therapeutics Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Biological Safety Testing Products and Services Market Segmentation, by Product
7.1 Chapter Overview
7.2 Reagents & Kits
7.2.1 Reagents & Kits Market Trends Analysis (2020-2032)
7.2.2 Reagents & Kits Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Instruments
7.3.1 Instruments Market Trends Analysis (2020-2032)
7.3.2 Instruments Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Services
7.4.1 Services Market Trends Analysis (2020-2032)
7.4.2 Services Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Biological Safety Testing Products and Services Market Segmentation, by Application
8.1 Chapter Overview
8.2 Vaccines & Therapeutics
8.2.1 Vaccines & Therapeutics Market Trends Analysis (2020-2032)
8.2.2 Vaccines & Therapeutics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.3 Vaccines
8.2.3.1 Vaccines Market Trends Analysis (2020-2032)
8.2.3.2 Vaccines Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.4 Monoclonal Antibodies
8.2.4.1 Monoclonal Antibodies Market Trends Analysis (2020-2032)
8.2.4.2 Monoclonal Antibodies Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.5 Recombinant Protein
8.2.5.1 Recombinant Protein Market Trends Analysis (2020-2032)
8.2.5.2 Recombinant Protein Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Blood & Blood-based Products
8.3.1 Blood & Blood-based Products Market Trends Analysis (2020-2032)
8.3.2 Blood & Blood-based Products Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Gene Therapy
8.4.1 Gene Therapy Market Trends Analysis (2020-2032)
8.4.2 Gene Therapy Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Tissue & Tissue-based Products
8.5.1 Tissue & Tissue-based Products Market Trends Analysis (2020-2032)
8.5.2 Tissue & Tissue-based Products Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Stem Cell
8.6.1 Stem Cell Market Trends Analysis (2020-2032)
8.6.2 Stem Cell Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Biological Safety Testing Products and Services Market Segmentation, by Test Type
9.1 Chapter Overview
9.2 Endotoxin Tests
9.2.1 Endotoxin Tests Market Trends Analysis (2020-2032)
9.2.2 Endotoxin Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Sterility Tests
9.3.1 Sterility Tests Market Trends Analysis (2020-2032)
9.3.2 Sterility Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Cell Line Authentication & Characterization Tests
9.4.1 Cell Line Authentication & Characterization Tests Market Trends Analysis (2020-2032)
9.4.2 Cell Line Authentication & Characterization Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Bioburden Tests
9.5.1 Bioburden Tests Market Trends Analysis (2020-2032)
9.5.2 Bioburden Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
9.6 Adventitious Agent Detection Tests
9.6.1 Adventitious Agent Detection Tests Market Trends Analysis (2020-2032)
9.6.2 Adventitious Agent Detection Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
9.7 Residual Host Contamination Detection Tests
9.7.1 Others Market Trends Analysis (2020-2032)
9.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9.8 Others
9.8.1 Others Market Trends Analysis (2020-2032)
9.8.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.4 North America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.6.2 USA Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.7.2 Canada Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.7.2 France Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Biological Safety Testing Products and Services Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.6.2 China Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.7.2 India Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.8.2 Japan Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.12.2 Australia Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Biological Safety Testing Products and Services Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Biological Safety Testing Products and Services Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.4 Africa Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.4 Latin America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Biological Safety Testing Products and Services Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11. Company Profiles
11.1 Lonza
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 BIOMÉRIEUX
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Thermo Fisher Scientific Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 SGS Société Générale de Surveillance SA
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Eurofins Scientific
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Sartorius AG
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Samsung Biologics
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Merck KGaA
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 BSL Bioservice
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Charles River Laboratories
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Market Segments:
By Product
Reagents & Kits
Instruments
Services
By Application
Vaccines & Therapeutics
Vaccines
Monoclonal Antibodies
Recombinant Protein
Blood & Blood-based Products
Gene Therapy
Tissue & Tissue-based Products
Stem Cell
By Test Type
Endotoxin Tests
Sterility Tests
Cell Line Authentication & Characterization Tests
Bioburden Tests
Adventitious Agent Detection Tests
Residual Host Contamination Detection Tests
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Epigenetics Market Size was valued at USD 15.2 Billion in 2023 and is expected to reach USD 66 Billion by 2032, growing at a CAGR of 17.7% over the forecast period 2024-2032.
The BOTOX Market Size was valued at USD 8.13 billion in 2023, and is expected to reach USD 16.25 billion by 2032, and grow at a CAGR of 8% over the forecast period 2024-2032.
The Long-term Care Software Market Size was valued at USD 4968.12 million in 2023 and is expected to reach USD 8919.94 million by 2032 and grow at a CAGR of 6.74% over the forecast period 2024-2032.
The Veterinary Vaccine Adjuvants Market size was valued at USD 9.18 billion in 2023 and is estimated to reach USD 15.24 billion by 2032 with a growing CAGR of 5.8% from 2024 to 2032.
The Continuous Glucose Monitoring Market Size was valued at USD 4.62 Billion in 2023, and is expected to reach USD 8.82 Billion by 2032, and grow at a CAGR of 7.80%.
The Airway Disease Treatment Market size was estimated at USD 2107.04 million in 2023 and is expected to reach USD 3233.65 million by 2031 at a CAGR of 5.5% during the forecast period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
